Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Liquidia Corporation stock logo
LQDA
Liquidia
$63.28
+5.3%
$43.00
$11.85
$63.46
$5.64B0.411.69 million shs770,892 shs
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$30.08
-1.2%
$31.81
$28.40
$38.79
$12.85B0.571.01 million shs752,114 shs
Solventum Corporation stock logo
SOLV
Solventum
$76.88
+0.8%
$69.09
$62.38
$88.20
$13.33B0.591.30 million shs1.83 million shs
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$82.74
-2.0%
$88.50
$79.12
$108.29
$16.01B0.482.29 million shs750,902 shs
Don't wait for the SpaceX IPO Cover

The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Liquidia Corporation stock logo
LQDA
Liquidia
-1.44%+0.20%+61.08%+100.33%+291.53%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
-0.25%-1.28%-3.63%-16.15%+6.21%
Solventum Corporation stock logo
SOLV
Solventum
-0.90%+1.99%+11.20%+1.58%+7.59%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
-1.10%-1.93%-7.45%-15.45%-9.02%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Liquidia Corporation stock logo
LQDA
Liquidia
$63.28
+5.3%
$43.00
$11.85
$63.46
$5.64B0.411.69 million shs770,892 shs
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$30.08
-1.2%
$31.81
$28.40
$38.79
$12.85B0.571.01 million shs752,114 shs
Solventum Corporation stock logo
SOLV
Solventum
$76.88
+0.8%
$69.09
$62.38
$88.20
$13.33B0.591.30 million shs1.83 million shs
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$82.74
-2.0%
$88.50
$79.12
$108.29
$16.01B0.482.29 million shs750,902 shs
Don't wait for the SpaceX IPO Cover

The space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Liquidia Corporation stock logo
LQDA
Liquidia
-1.44%+0.20%+61.08%+100.33%+291.53%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
-0.25%-1.28%-3.63%-16.15%+6.21%
Solventum Corporation stock logo
SOLV
Solventum
-0.90%+1.99%+11.20%+1.58%+7.59%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
-1.10%-1.93%-7.45%-15.45%-9.02%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Liquidia Corporation stock logo
LQDA
Liquidia
2.92
Moderate Buy$49.33-22.04% Downside
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
2.50
Moderate Buy$30.932.83% Upside
Solventum Corporation stock logo
SOLV
Solventum
2.50
Moderate Buy$84.259.59% Upside
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
2.26
Hold$102.8024.25% Upside

Current Analyst Ratings Breakdown

Latest LQDA, ZBH, SOLV, and SNN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/25/2026
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
Reiterated RatingBuy
5/15/2026
Solventum Corporation stock logo
SOLV
Solventum
Initiated CoverageOutperform$94.00
5/14/2026
Solventum Corporation stock logo
SOLV
Solventum
DowngradeBuyNeutral$50.00
5/12/2026
Liquidia Corporation stock logo
LQDA
Liquidia
Boost Price TargetBuy$55.00 ➝ $67.00
5/12/2026
Liquidia Corporation stock logo
LQDA
Liquidia
Boost Price TargetOverweight$51.00 ➝ $62.00
5/11/2026
Liquidia Corporation stock logo
LQDA
Liquidia
Reiterated RatingBuy$60.00
5/11/2026
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
Set Price Target$31.85
5/11/2026
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
Lower Price TargetHold$32.00 ➝ $30.00
5/11/2026
Liquidia Corporation stock logo
LQDA
Liquidia
Boost Price TargetBuy$54.00 ➝ $70.00
5/11/2026
Liquidia Corporation stock logo
LQDA
Liquidia
Boost Price TargetBuy$50.00 ➝ $59.00
5/6/2026
Solventum Corporation stock logo
SOLV
Solventum
Lower Price TargetNeutral$82.00 ➝ $78.00
(Data available from 5/27/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Liquidia Corporation stock logo
LQDA
Liquidia
$288.07M19.54N/AN/A$1.22 per share51.87
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$6.16B2.08$3.38 per share8.90$12.45 per share2.42
Solventum Corporation stock logo
SOLV
Solventum
$8.26B1.61$8.99 per share8.55$28.69 per share2.68
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$8.23B1.94$13.30 per share6.22$65.55 per share1.26
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Liquidia Corporation stock logo
LQDA
Liquidia
-$68.92M$0.14453.2013.16N/A7.74%46.82%7.06%8/11/2026 (Estimated)
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$625MN/AN/A11.981.00N/AN/AN/A8/4/2026 (Estimated)
Solventum Corporation stock logo
SOLV
Solventum
$1.56B$8.169.4310.801.1917.33%23.51%7.63%8/6/2026 (Estimated)
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$705.20M$3.8521.499.221.989.05%13.24%7.28%8/6/2026 (Estimated)

Latest LQDA, ZBH, SOLV, and SNN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/11/2026Q1 2026
Liquidia Corporation stock logo
LQDA
Liquidia
$0.4102$0.52+$0.1098$0.52$119.44 million$132.87 million
5/5/2026Q1 2026
Solventum Corporation stock logo
SOLV
Solventum
$1.35$1.48+$0.13$0.07$1.97 billion$2.01 billion
4/28/2026Q1 2026
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$1.86$2.09+$0.23$1.22$2.07 billion$2.09 billion
3/18/2026Q4 2025
Liquidia Corporation stock logo
LQDA
Liquidia
$0.01$0.15+$0.14N/AN/AN/A
3/5/2026Q4 2025
Liquidia Corporation stock logo
LQDA
Liquidia
$0.08$0.15+$0.07$0.15$87.49 million$92.02 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Liquidia Corporation stock logo
LQDA
Liquidia
N/AN/AN/AN/AN/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$0.933.09%N/AN/AN/A
Solventum Corporation stock logo
SOLV
Solventum
N/AN/AN/AN/AN/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$0.961.16%N/A24.94%N/A

Latest LQDA, ZBH, SOLV, and SNN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/22/2026
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
quarterly$0.241.12%6/25/20266/25/20267/31/2026
3/5/2026
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$0.48203.04%3/27/20263/27/20265/27/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Liquidia Corporation stock logo
LQDA
Liquidia
1.18
2.22
2.03
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
0.60
2.57
1.25
Solventum Corporation stock logo
SOLV
Solventum
0.96
1.07
0.75
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.50
1.73
0.95

Institutional Ownership

CompanyInstitutional Ownership
Liquidia Corporation stock logo
LQDA
Liquidia
64.54%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
25.64%
Solventum Corporation stock logo
SOLV
Solventum
N/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
88.89%

Insider Ownership

CompanyInsider Ownership
Liquidia Corporation stock logo
LQDA
Liquidia
25.60%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
1.00%
Solventum Corporation stock logo
SOLV
Solventum
0.24%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
1.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
Liquidia Corporation stock logo
LQDA
Liquidia
5088.93 million66.16 millionOptionable
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
16,988426.99 million422.72 millionOptionable
Solventum Corporation stock logo
SOLV
Solventum
20,000173.18 million172.76 millionOptionable
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
17,000193.46 million190.99 millionOptionable

Recent News About These Companies

5 Best Robotic Surgery Stocks to Buy

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Liquidia stock logo

Liquidia NASDAQ:LQDA

$63.28 +3.18 (+5.29%)
As of 02:28 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Smith & Nephew SNATS stock logo

Smith & Nephew SNATS NYSE:SNN

$30.08 -0.36 (-1.17%)
As of 02:27 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

Solventum stock logo

Solventum NYSE:SOLV

$76.88 +0.61 (+0.80%)
As of 02:28 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

Zimmer Biomet stock logo

Zimmer Biomet NYSE:ZBH

$82.74 -1.67 (-1.98%)
As of 02:28 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.